Guggenheim Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.73M | Sell |
11,333
-333
| -3% | -$51K | 0.01% | 750 |
|
|
2025
Q4 | $1.61M | Sell |
11,666
-566
| -5% | -$74.1K | 0.01% | 739 |
|
|
2025
Q3 | $1.57M | Buy |
12,232
+278
| +2% | +$33.9K | 0.01% | 767 |
|
|
2025
Q2 | $1.45M | Sell |
11,954
-1,761
| -13% | -$198K | 0.01% | 762 |
|
|
2025
Q1 | $1.53M | Buy |
13,715
+1,147
| +9% | +$122K | 0.01% | 717 |
|
|
2024
Q4 | $1.22M | Sell |
12,568
-1,706
| -12% | -$182K | 0.01% | 825 |
|
|
2024
Q3 | $1.64M | Sell |
14,274
-5,745
| -29% | -$652K | 0.01% | 884 |
|
|
2024
Q2 | $2.13M | Buy |
20,019
+3,516
| +21% | +$353K | 0.02% | 793 |
|
|
2024
Q1 | $1.6M | Buy |
16,503
+269
| +2% | +$27.6K | 0.01% | 976 |
|
|
2023
Q4 | $1.64M | Buy |
16,234
+1,960
| +14% | +$189K | 0.01% | 929 |
|
|
2023
Q3 | $1.45M | Sell |
14,274
-340
| -2% | -$34.5K | 0.01% | 934 |
|
|
2023
Q2 | $1.47M | Sell |
14,614
-1,337
| -8% | -$134K | 0.01% | 985 |
|
|
2023
Q1 | $1.47M | Buy |
15,951
+4,330
| +37% | +$378K | 0.01% | 989 |
|
|
2022
Q4 | $1.05M | Buy |
11,621
+5,905
| +103% | +$497K | 0.01% | 1133 |
|
|
2022
Q3 | $435K | Buy |
5,716
+289
| +5% | +$24K | ﹤0.01% | 1533 |
|
|
2022
Q2 | $458K | Sell |
5,427
-504
| -8% | -$44.2K | ﹤0.01% | 1613 |
|
|
2022
Q1 | $520K | Sell |
5,931
-3,527
| -37% | -$305K | ﹤0.01% | 1676 |
|
|
2021
Q4 | $828K | Buy |
9,458
+1,648
| +21% | +$137K | ﹤0.01% | 1456 |
|
|
2021
Q3 | $639K | Sell |
7,810
-1,179
| -13% | -$106K | ﹤0.01% | 1645 |
|
|
2021
Q2 | $820K | Sell |
8,989
-2,920
| -25% | -$260K | ﹤0.01% | 1596 |
|
|
2021
Q1 | $1.02M | Sell |
11,909
-4,577
| -28% | -$411K | 0.01% | 1395 |
|
|
2020
Q4 | $1.56M | Sell |
16,486
-6,477
| -28% | -$566K | 0.01% | 1096 |
|
|
2020
Q3 | $2M | Sell |
22,963
-5,345
| -19% | -$463K | 0.01% | 898 |
|
|
2020
Q2 | $2.47M | Sell |
28,308
-1,190
| -4% | -$103K | 0.02% | 787 |
|
|
2020
Q1 | $2.43M | Sell |
29,498
-3,557
| -11% | -$317K | 0.02% | 704 |
|
|
2019
Q4 | $3.13M | Sell |
33,055
-5,588
| -14% | -$501K | 0.02% | 848 |
|
|
2019
Q3 | $3.36M | Buy |
38,643
+4,264
| +12% | +$383K | 0.03% | 791 |
|
|
2019
Q2 | $3.14M | Sell |
34,379
-14,966
| -30% | -$1.27M | 0.03% | 844 |
|
|
2019
Q1 | $4.25M | Buy |
49,345
+13,062
| +36% | +$1.05M | 0.03% | 706 |
|
|
2018
Q4 | $2.79M | Sell |
36,283
-14,675
| -29% | -$1.14M | 0.02% | 872 |
|
|
2018
Q3 | $3.93M | Buy |
50,958
+6,288
| +14% | +$465K | 0.03% | 857 |
|
|
2018
Q2 | $3.02M | Sell |
44,670
-3,844
| -8% | -$265K | 0.02% | 1011 |
|
|
2018
Q1 | $3.52M | Buy |
48,514
+1,270
| +3% | +$96.7K | 0.01% | 1237 |
|
|
2017
Q4 | $3.56M | Sell |
47,244
-8,516
| -15% | -$643K | 0.01% | 1240 |
|
|
2017
Q3 | $4.29M | Buy |
55,760
+2,020
| +4% | +$153K | 0.01% | 1161 |
|
|
2017
Q2 | $4.02M | Buy |
53,740
+4,829
| +10% | +$342K | 0.01% | 1141 |
|
|
2017
Q1 | $3.25M | Buy |
48,911
+5,436
| +13% | +$362K | 0.01% | 1288 |
|
|
2016
Q4 | $2.84M | Sell |
43,475
-40,948
| -49% | -$2.66M | 0.01% | 1412 |
|
|
2016
Q3 | $5.97M | Buy |
84,423
+19,508
| +30% | +$1.42M | 0.02% | 917 |
|
|
2016
Q2 | $4.8M | Sell |
64,915
-19,641
| -23% | -$1.36M | 0.02% | 1025 |
|
|
2016
Q1 | $5.49M | Sell |
84,556
-7,881
| -9% | -$536K | 0.02% | 948 |
|
|
2015
Q4 | $7.13M | Sell |
92,437
-63,248
| -41% | -$5.02M | 0.02% | 879 |
|
|
2015
Q3 | $12.8M | Sell |
155,685
-22,795
| -13% | -$2.03M | 0.04% | 661 |
|
|
2015
Q2 | $15.7M | Buy |
178,480
+3,652
| +2% | +$335K | 0.04% | 674 |
|
|
2015
Q1 | $15.4M | Sell |
174,828
-4,164
| -2% | -$369K | 0.04% | 701 |
|
|
2014
Q4 | $14.9M | Sell |
178,992
-22,009
| -11% | -$1.82M | 0.04% | 706 |
|
|
2014
Q3 | $17M | Sell |
201,001
-11,191
| -5% | -$905K | 0.04% | 704 |
|
|
2014
Q2 | $17.2M | Buy |
212,192
+3,506
| +2% | +$276K | 0.04% | 712 |
|
|
2014
Q1 | $15.9M | Buy |
208,686
+29,961
| +17% | +$2.18M | 0.05% | 718 |
|
|
2013
Q4 | $12.9M | Buy |
178,725
+37,648
| +27% | +$2.62M | 0.04% | 748 |
|
|
2013
Q3 | $9.7M | Buy |
141,077
+16,172
| +13% | +$1.07M | 0.03% | 854 |
|
|
2013
Q2 | $7.91M | Buy |
+124,905
| New | +$8.13M | 0.03% | 868 |
|
Other funds holding NVS
Guggenheim Capital's NVS Position: Q1 2026 in Review
Guggenheim Capital reduced its Novartis (NVS) stake by 2.9% in Q1 2026, selling an estimated $51K and leaving 11,333 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #750.
Guggenheim Capital first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.2M in Q2 2014. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Guggenheim Capital held 11,333 shares of Novartis worth $1.73M as of Q1 2026.
- Guggenheim Capital sold 333 Novartis shares in Q1 2026, an estimated $51K.
- Novartis made up 0.01% of Guggenheim Capital's portfolio in Q1 2026, its #750 holding.
- Guggenheim Capital first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's Novartis position peaked at $17.2M in Q2 2014.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.